Floatz logo

Zoledronate

Wilms Tumor

University of FloridaSmall moleculePhase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
89/ 100

Competitive context

39 Active assets in the Wilms Tumor cohort.

Asset / SponsorPhaseRating
Inno-206
Children's National Research Institute
Phase 2BB
(+)-VINCRISTINE
Centre Oscar Lambret
Phase 2BB
Itraconazole
Samsung Medical Center
Phase 4BB
Irinotecan
Centre Oscar Lambret
Phase 2BB
Cyclophosphamide
St. Jude Children's Research Hospital
Phase 2BB

View all 50 →

Same molecule, other indications

Zoledronate is also rated in:

metastatic carcinoma in the boneDormant
BBB
Indicative ·
79 / 100
View asset →
osteoporosisDormant
BBB
Indicative ·
76 / 100
View asset →
breast carcinomaDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →